Results 131 to 140 of about 2,680 (197)

Efficacy of eravacycline in difficult-to-treat (DTR) Acinetobacter baumannii bacteraemia in ICU: a case report. [PDF]

J Antimicrob Chemother
Melchio M, Portunato F, Vena A, Porcile E, Centanaro M, Bassetti M.   +5 more
europepmc   +1 more source

Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>. [PDF]

Infect Drug Resist
Chen D, Lan H, Yang W, Tian D, Liu Y, Ju L, Song Q, Min R, Wang Y, Li Y, Wang P, Cao J.   +11 more
europepmc   +1 more source

Erratum: Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> [Corrigendum]. [PDF]

Infect Drug Resist
europepmc   +1 more source

Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use [PDF]

Antonelli, Massimo, Cortegiani, Andrea, Giarratano, Antonino, Giordano, Alessio, Mastroianni, Claudio, Rossolini, Gian Maria, Stefani, Stefania, Tumbarello, Mario, Viaggi, Bruno   +8 more
core   +4 more sources

Therapeutic challenges and emerging strategies against carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]

Curr Res Microb Sci
Yang C, Li J, Luo X, Song Z, Zhang J.
europepmc   +1 more source

Efficacy of eravacycline on carbapenem resistant Enterobacterales in vitro

, 2019
The main obstacle in treatment of infections caused by carbapenem-resistant Enterobacterales (CRE) are limited treatment options. The novel antimicrobial agents other than β-lactams with activity not being dependent on β-lactamase class are especially important.
openaire   +1 more source

Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Fan M, Zhang Z, Liu X, Deng L, Lei Y, Chen F, Ying Y, Fan C, Gao J, Ren Z, Gu J, Xia Y, Yuan Y, Zhang K, Zhu J, Yang Y, Sun W, Cheng K, Carattoli A, Tang CM, Shen Z, Liu G.   +21 more
europepmc   +1 more source

Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing <i>Enterobacter cloacae</i>. [PDF]

Antibiotics (Basel)
Keck JM, Dare RK, Saccente M, Vyas KS, Thompson RN.   +4 more
europepmc   +1 more source

A One Health Perspective on the Plasmid Backbone Preference and Evolutionary Adaptation of <i>tmexCD-toprJ</i> in <i>Klebsiella spp</i>. [PDF]

Infect Drug Resist
Jiang X, Liu F, Chai J, Li X, Li Y, Fu S, Li Y.   +6 more
europepmc   +1 more source

Can we escape from top-priority ESKAPE pathogens? [PDF]

Emerg Microbes Infect
Zeng L, Feng Y, Wang M.
europepmc   +1 more source